|21 July, 2019

Julphar bolsters management team with new senior appointments   

Manoj Pananchukunnath has been appointed as Chief Scientific Officer.

RAS AL KHAIMAH, UAE /PRNewswire/ -- Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, has announced the appointment of new executive employees to help guide the company towards profitability and long-term success.

Jerome Carle, Chief Executive Officer at Julphar said: "We have set forward a new broad reaching strategy that will make us stronger as an organization and help us remain competitive and innovative. A key part of our strategy is ensuring we have the very best people in place.

"We are thrilled to welcome such strong additions to our Management Team. Each new appointment brings a wealth of experience and expertise that will complement our existing talents extremely well. Their innovative thinking and fresh perspectives will be invaluable as we build momentum towards a revitalized and stronger Julphar."

Manoj Pananchukunnath has been appointed as Chief Scientific Officer. He will oversee the scientific functions of the company and will be tasked with improving efficiency across R&D, Medical Affairs and Regulatory Affairs as well as developing and implementing strategic change. He joins Julphar from Mylan where he was the Head of Global Injectable Scientific Affairs.

Georges Ibrahim is the new Chief Quality Officer. He will oversee the quality functions of the company and will be tasked with improving efficiency across Quality Assurance, Quality Control and Technical Compliance. Ibrahim brings 15 years of industry experience, most recently from Novartis Germany where he was site Production Head.

Omair Ahmed assumes the role of Interim Chief Finance Officer having previously held the position of Chief Financial Officer at Julphar Saudi Arabia. He joined Julphar from Al Borg Diagnostics where he was the Chief Financial Officer. Ahmed has more than 20 years' experience in Finance and Auditing and began his career at KPMG and PwC.

Jacques Safarian has been appointed as the Chief Commercial Officer in charge of Sales, Global Marketing, Business Support and MEBO Marketing, having previously held the position of Africa Region Director. He brings a wealth of experience of international markets and broad knowledge of the pharmaceutical industry and has worked with leading companies including Grimberg, Bioderma and Aventis Pasteur.

Samir Mardini has been appointed as the Chief Human Resources Officer at Julphar. He started his career with PwC, before first joining IBM and then Baker Hughes. He has also held positions as Head of Talent Practice MENA at Aon Hewitt, Associate Director at Korn Ferry and CHRO at Investment and Development Office, Government of Ras Al Khaimah.

Rita Karam is Julphar's new Head of Legal Affairs. She has more than 15 years' experience in corporate law, negotiations, compliance, litigation, arbitration and legal restructuring gained in the region with international organizations including PepsiCo, Unilever and most recently, AbbVie.

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases